TO REVIEW THE literature on endovascular therapies available to clinicians to aid in the management of head, neck, and intracranial tumors. Hypervascular tumors of the head and neck region, as well as the intracranial region, are associated with large amounts of blood loss intraoperatively. Preoperative embolization of selected hypervascular tumors has been proposed in the literature as a method of reducing blood loss intraoperatively. This technique involves superselective catheterization of the feeding arteries to the tumor bed and then by infusion of embolic particles to saturate the tumor bed in the hopes of inducing necrosis. For less vascular tumors, selective infusion of chemotherapeutic agents has been reported as a method of reducing the systemic toxic effects of these medications. Endovascular therapies for hypervascular and less vascular tumors hold promise, although multicenter randomized controlled trials are required to help identify the patients that will benefit the most.
T
here are roughly 39,000 new cases of central nervous system (CNS) tumors (46) and 37,000 new cases of head and neck cancer (64) diagnosed in the United States each year. Embolization of these tumors has become an important adjunct to the surgical treatment of these tumors. In addition to facilitating surgery, they can be used in isolation as palliative treatment for nonresectable tumors and for delivering chemotherapeutic agents. One of the earliest reported cases of a successful embolization was in 1974 by Hekster et al. (29) . Since then, many reports or series have been published examining the potential benefits of this therapy, but no consensus has been reached. Endovascular therapies are not limited to embolization procedures for head and neck tumors. Nonvascular CNS tumors, such as lymphomas, can be treated with bloodbrain barrier (BBB) disruption, and squamous cell carcinomas (SCC) can be treated with intra-arterial chemotherapy infusions. In this review, we will discuss the endovascular management of CNS and head and neck tumors.
INDICATIONS AND GENERAL PRINCIPLES
Embolization is generally used only in the management of vascular tumors. Table 1 summarizes the indications for embolization of tumors. Table 2 summarizes the common hypervascular tumors that are treated with embolization preoperatively.
Embolizations can be performed by either an endovascular approach or direct injection of embolic agents into the tumor. The aim of embolization is to devascularize the tumor bed by saturating these capillaries, with the hope of promoting tumor necrosis. Sacrificing proximal arterial feeders will do little to help with this endeavor. The smallest particles that are feasible should be used with embolization to penetrate the small capillary beds. The size of these capillary beds varies based on tumor pathology. The limiting factor in using smaller particles is recognition of dangerous anastamoses that can occur between the external carotid artery (ECA) and internal carotid artery (ICA) branches and arteriovenous shunting within the tumor bed. Table 3 lists some of these anastomoses (71) . In addition, there is blood supply to vital structures such as cranial nerves and nerve roots via ECA and vertebral artery branches as listed in Table 4 . In general, particles smaller than 150 m in diameter and liquid embolization should be avoided if these anastamoses are seen or if embolization is being performed in branches supplying cranial nerves or nerve roots (7) .
Embolic material can be divided into three major categories: liquid, particulate, and coils. Table 5 summarizes these various embolic agents and the advantages and disadvantages of each of them. Liquid and particulate agents are used primarily to aid in necrosing of the tumor capillary bed when the microcatheter can be placed in a safe position. Selection of each agent is based on location of the feeding artery (i.e., risk of injuring normal structures) and the desired effect in relation to the planned surgery. If surgery is planned within a few days of embolization, selection of temporary occlusive materials such as particles is reasonable. Fibered and nonfibered detachable coils are used to sacrifice the feeding pedicle to reduce the rate of recanalization, especially when using particulate embolization.
TECHNIQUES
A diagnostic angiogram is performed using the transfemoral technique with cannulation of the common carotid arteries and selective injection of the ICA and ECA. Selective catheterizations of the feeding vessels are performed to provide complete vascular mapping of these lesions. Embolization procedures are initiated with superselective catheterization of the distal most vessel. By entering the distal most vessel, the operator avoids the problem of proximal vasospasm precluding embolization of more distal vessels. On entering the distal arterial feeding vessel to the tumor bed, the feeding pedicles are tested for supply to cranial nerves. An injection of 3 ml of lidocaine is administered, and the patient is tested for cranial nerve and vision deficits before embolization proceeds. If the patient does not incur a deficit with testing, the tumor's capillaries are slowly saturated with embolic particles under constant fluoroscopic guidance. It is important to maintain a slow but steady injection rate while watching for reflux of particles, which would signal the operator to stop injecting. Once the tumor is saturated, the proximal feeding vessel is occluded with either Gelfoam (Upjohn Co., Kalamazoo, MI) or platinum coils before the process is repeated on the next most distal vessel and on through all of the feeding vessels.
For tumors with small arterial feeders coming off larger vessels supplying normal neural structures, we use a technique of liquid embolization using alcohol. By temporarily occluding the larger vessel with a balloon distal to the feeding artery site, we have found that alcohol can be safely injected into these small feeders to aid in devascularizing a tumor (32) . Others have described similar techniques (80) . However, this technique is still controversial because it can lead to complications. After the balloon is deflated, particles may still be floating in the ICA, and they might distally embolize and cause stroke. Periprocedurally, it is important to ensure that the patient is well hydrated with intravenous fluids to help protect the kidneys from the iodinated contrast load. Postembolization, patients undergo surgical resection within 7 days. This is to avoid neovascularization and new collaterals that can form rapidly. Swelling after embolization is often a concern, and patients can be treated with steroids pre-and postprocedure to help reduce edema.
MENINGIOMAS
Meningiomas account for roughly 15% of all intracranial tumors and typically occur in adults between the ages of 40 and 60 years (71) . These tumors can be cured through surgical excision (1), although considerable debate exists in the literature as to the advantages of presurgical embolization.
Meningiomas are usually supplied by dural arteries. These arteries include the middle meningeal artery, accessory meningeal, ascending pharyngeal, or occipital transmastoidperforating branches of the ECA. Dural arteries also include the tentorial and inferolateral trunk branches of the ICA, as well as the posterior meningeal branch of the vertebral artery. There is often additional supply derived from pial vessels (56) . The vascular supply to meningiomas typically varies based on the location of the tumor ( Table 6 ).
The aim of embolization is to help reduce blood loss intraoperatively and induce necrosis of the tumor (81) . Studying the effectiveness of embolization has been challenging because of the varied sizes, location, and vascular supply to meningiomas. In addition, most studies have relied on subjective reports of blood loss during surgeries, although recent studies have considered gadolinium enhancement on magnetic resonance imaging as a marker of efficacy (25) . Figure 1 shows an example of pre-and postembolization treatment of a sphenoid wing meningioma with marked reduction in gadolinium enhancement. A reduced perioperative blood loss was highly correlated with a reduction in the degree of gadolinium enhancement (25) . One of the larger randomized controlled trials has shown that preoperative embolization can reduce blood transfusions perioperatively and may also be more cost-effective in treating patients with meningiomas (14) . Wakhloo et al. (81) showed that the blood loss was moreover related to the size of particles used during embolization. A 500-to 2600-ml perioperative blood loss was noted in 70% of cases in which polyvinyl alcohol (PVA) particles that were 150 to 300 m in diameter were used. When PVA particles that were 50 to 150 m in diameter were used, the blood loss was less than 500 ml in all but two patients of a total of 20 patients. In those two patients, the blood loss was limited to 800 ml. On histological examination, it was noted that 15 out of the 20 patients treated with particles 50 to 150 m in diameter had evidence of particles in the tumor capillary bed (81). Superselective angiography of the feeding vessels with mi- crocatheters aids with planning the size and type of materials that will be used during the procedure. The purpose of this technique is to lay out the dangerous anastomoses that can occur, especially from the ECA circulation. Some of the complications reported in the literature occur from the opening of these anastomoses during embolization. If a dangerous anastomosis is identified, the catheter is repositioned or the anastomosis is occluded using a microcoil. Provocative testing is performed as described before with lidocaine to identify blood supply to cranial nerves. If neurological changes occur with lidocaine testing, the catheter is repositioned and the test is repeated. The other option would be to use particles larger in diameter than the vasa nervorum, which would be at least 300 m.
Particulate material such as PVA and Trisacryl gelatin microspheres are commonly used for embolization (81) . The permanence of liquid agents, such as alcohol and cyanoacrylate, is not needed because most of these lesions are resected after embolization. Moreover, liquid agents are riskier because they can cross the anastomotic channels and can cause damage of important neural structures. Other agents that have been used include fibrin glue, lyophilized dura Gelfoam particles, and n-butylcyanoacrylate (47, 62) . Embolization is done slowly, and vigorous embolization is avoided to prevent reflux of embolic material into normal proximal branches. The pial supply is generally not embolized because of the higher risk of stroke.
This emphasizes the importance of using smaller particles, but care must be taken because this also increases the risk of the procedure. A risk of using particles less than 150 m in diameter is injuring cranial nerves via the vasa nervorum (43) . Embolization procedures should be performed distally to these branches if smaller particles are to be used. Larger particles can be used if the catheter is proximal to branches supplying normal structures.
Large centers report low complication rates with embolization of meningiomas. Berenstein et al. (7) reported that three patients out of 185 (1.6%) developed permanent neurological deficits as a result of embolization, whereas five (2.7%) had transient neurological events. Our experience at the University of Pittsburgh combined with the University of Texas Southwestern Medical Center has shown that four patients out of 111 (3.6%) developed cranial nerve injury or monocular blindness as a result of embolization. The two patients who developed blindness were embolized with 50-to 150-m PVA particles despite passing provocative testing with lidocaine.
A technique using temporary balloon occlusion has been used for branches of the ICA that may feed the tumor. The authors inflated a balloon distal to the tumor's arterial feeders and then injected PVA particles, thereby occluding the arterial feeders to the tumor (80) . As noted earlier, this technique is controversial and requires further study. Embolization of meningiomas is feasible and can be done safely at an experienced center, although the risk of this procedure may elevate with the use of smaller particles (81) . Preliminary data from case series and single-center randomized trials seem to favor the use of this method for larger tumors, although larger clinical trials are required to delineate the precise role of embolization.
PARAGANGLIOMAS
Paragangliomas are derived from neuroendocrine cells and are a rare entity in the head and neck region. The most common location in the head and neck region for these tumors is along the temporal bone involving the tympanic nerve or jugular fossa, followed by the carotid bifurcation and vagus nerve (4, 74) . Angiographically, the typical appearance involves the "splaying" of the carotid bifurcation, with an intense blush denoting its hypervascularity (39) . Clinical presentation for these tumors varies based on location. Table 7 outlines the names given to paragangliomas based on location along with typical clinical presentations. These tumors can be multicentric, although this is more common in patients with a positive family history (21, 26, 61) . Paragangliomas rarely secrete catecholamines, especially when they are located at the carotid bifurcation, although patients with labile hypertension should arouse clinical suspicion (63, 66) .
It has generally been accepted that definitive treatment for these tumors involves surgical excision. A recent review of the case series presented between 1992 and 1995 of 178 patients undergoing surgical excision of carotid body tumors showed a 0% mortality, 2.2% rate of stroke, and 22% rate of cranial nerve palsies (54) . This was in contrast to earlier reports from the 1940s, which had shown a 40% morbidity from excision (52) . Preoperative arterial embolization has been used for select cases of head and neck paragangliomas. Because these tumors are rare, it is difficult to study the potential benefits of embolization. Currently, reports from experienced centers have helped in the identification of patients who may potentially benefit from embolization (60) .
Preoperative angiography is considered vital by many surgeons because it can aid in determining the arterial supply to the tumor based on vessels that have been displaced (36) . In addition, the circle of Willis can help determine how safe it is to temporarily occlude the carotid artery during surgery (60) . Once arteriography has been performed, a decision must be made as to the benefits and risks of arterial embolization. These surgeries can often result in significant blood loss of up to 2 L (28). Tikkakoski et al. (78) compared blood loss between patients embolized before surgical excision with that of nonembolized patients and showed a significantly lower amount of blood loss in the embolization group (588 versus 1374 ml, P Ͻ 0.04) (78) . Much of this decision rests on the experience of the interventionalist, along with location and size of the tumor.
It is generally felt that larger tumors will likely benefit from embolization (33, 40) , although a cutoff value for size has never been established. Arterial supply to these tumors often involves branches from the ECA and ICA, but almost all patients have some supply from the ascending pharyngeal arteries (60) . Figure 2 shows an example of a typical carotid body tumor with supply from the ascending pharyngeal artery. Different techniques for embolization have been described in the literature. Many advocate catheter placement in the distal part of the feeding vessel with fluoroscopy-guided administration of embolic particles such as PVA, Gelfoam, or cyanoacrylate. Administration should occur with continuous fluoroscopy, and care should be taken to avoid reflux of particles into the normal circulation (33) . Proximal embolization of feeding vessels often does not help with reduction of blood loss because ICA collaterals can develop around the tumor. In addition, access to further embolization procedures is lost (60) . The capillary bed to these tumors is roughly 200 m, and thus 150-to 250-m particles are usually appropriate (7). Catheter-directed embolization can be performed safely, as shown in a series of 47 patients from New York University. Only one patient had a permanent sequela (facial nerve palsy after the procedure); three patients had cranial nerve palsies but also had tumor encapsulating those nerves, one patient had an asymptomatic dissection, and one patient had a transient hemiparesis (60) . Surgical excision should occur within 1 week after embolization to ensure that the new collaterals do not form in the interim.
When a large number of branches come off of the ICA and feed the tumor, consideration can be given to a balloon test occlusion. At our institution, we use xenon computed tomography as a physiological test (77) to determine patient tolerance to a balloon test occlusion. If a patient tolerates the occlusion, consideration can be given to sacrificing the ICA, although some have recently reported the use of grafted stents to maintain ICA patency while excluding arterial feeders to the tumor (12) . Others have reported success with direct percutaneous injection of cyanoacrylate or alcohol into these hypervascular tumors, with successful devascularization of the tumor, but without significant complications (9) . Paragangliomas prove to be challenging tumors to treat and require a team approach towards the goal of successful removal. Endovascular approaches can be used to help reduce blood loss through devascularization of the tumor bed.
HEMANGIOPERICYTOMA
Hemangiopericytoma is a rare tumor of the CNS that accounts for roughly 1% of all intracranial tumors and 2 to 4% of meningiomas (24, 27) . These tumors often present clinically and have radiographic features that are similar to those of meningiomas. On magnetic resonance imaging scans, hemangiopericytomas are less likely to have associated calcifications and may have a tendency to uptake contrast in a heterogenous pattern (13, 58) . Based on a small number of case series in the literature, it is felt that these tumors have a higher frequency of recurrence in comparison with meningiomas (27) . Currently, most authors recommend a radical surgical excision of these tumors (3) .
Angiographically, these tumors are typically supplied by branches coming off the ICA and vertebrobasilar circulation and, occasionally, branches from the ECA. The classic feature to the tumor is an intense tumor blush followed by a longlasting venous phase, along with corkscrew-type vessels within the tumor itself (2, 49) .
These tumors are highly vascular and associated with large amounts of blood loss intraoperatively. Earlier reports note intraoperative mortality attributable to blood loss from surgical resection (34) . Presurgical embolization has been performed in a limited number of cases in the literature. In addition, direct tumor embolization through percutaneous entry has also been described (23) .
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA
Juvenile nasopharyngeal angiofibroma (JNA) is a rare tumor of adolescence that most commonly affects males (55) , although there are rare reports involving females (30) . The typical clinical presentation for patients presenting with a JNA is unilateral nasal obstruction with epistaxis. These masses are highly vascular and are associated with arteriovenous fistulae that generate increased feeding artery pressures (73) and may extend intracranially in 10 to 20% of cases (35) . JNAs can be staged according to the Fisch classification system (18) ( Table 8) , and surgical excision has been advocated by many authors (59) . Despite removal of these tumors, recurrence rates have been reported between 20 and 40% (17, 65) . Recurrence rates are most likely related to initial staging of the tumor (45) .
The role of preoperative embolization for these vascular tumors has been debated in the literature (51, 53) . As with other vascular tumor surgeries, presurgical embolization seems to reduce blood loss during surgery (45, 48, 72) . In addition, it may be useful in larger tumors and those extending intracranially because devascularization can help shrink the tumor and make surgical excision easier. The majority of the blood supply comes from the internal maxillary artery, sphenopalatine artery, ascending pharyngeal artery, and smaller branches off the carotid artery (41) . Angiography of both carotid systems is necessary because supply can be bilateral in 30% of patients and from branches of the ICA in 30% of patients (59) . Figure 3 shows the typical radiographic features of a JNA tumor pre-and postembolization.
Complication rates from these procedures reported in the literature seem to be low at experienced centers (42, 48) . Many of the complications reported in the literature are attributable to poor recognition of dangerous anastomoses, inappropriate embolic material, and size or reflux of particles (59) . There has been concern that embolization may be a risk factor for recur- rence of tumor, although this was from a small series of 33 patients (51).
As with other embolization procedures, if significant blood supply occurs from the ICA, some have used balloon inflation distally to the branches, but proximally to the ophthalmic artery. Particles are then released into the ICA under continuous fluoroscopy to watch for reduction of tumor blush via these ICA branches. Saline can be infused after ceasing embolization to dilute the particles before deflation of the balloon (20) . In addition, direct puncture of the tumor can be performed with an 18-gauge needle followed by injection of cyanoacrylate. This can be used in patients with prior proximal ligations within the ECA, thereby restricting endovascular access to feeding arteries; it can also be used in patients with a large supply from ICA branches (79) . There are few reports of this technique, and further study is required to assess safety and efficacy.
As with the other tumors discussed thus far, no multicenter large clinical trial data are available to help define the role of embolization of JNAs. These tumors can be safely embolized, although the single-center report of embolization procedures leading to an increased rate of recurrence (51) is concerning.
SQUAMOUS CELL CARCINOMA
SCC is the most common tumor of the head and neck region and is most commonly treated with a combination of surgical resection and radiation therapy. Unfortunately, long-term survival is poor for patients with advanced disease (15) . Surgery can often be disfiguring, with associated difficulties in swallowing and chewing secondary to resection of the oral mucosa (68) . Cisplatin with or without 5-fluorouracil is used as the chemotherapy regimen for SCC, but it has toxic side effects with escalating doses (37) . Intra-arterial administration of cisplatin has been used in limited centers as an alternative to systemic chemotherapy.
Intra-arterial administration of cisplatin into the feeding vessels of the tumor offers the advantage of reduced systemic toxicity along with the ability to give higher doses of the medication. A second problem with systemic doses of cisplatin is that resistance may develop after a few doses, thereby rendering this therapy ineffective (5) . Giving higher doses may potentially offset resistance and help induce the tumorcidal effects of cisplatin (67) .
These tumors are generally avascular; thus, embotherapy is difficult to perform. Infusion of chemotherapy via intraarterial means has not gained widespread acceptance, although many reports have been published in the literature showing the potential benefits of this approach (7, 69) . These tumors are fed by ECA branches and can be accessed via catheterization of the femoral artery. The catheter can be placed in the proximal ECA before determining which vessels supply the tumor. The catheter is then advanced into the feeding vessel, where infusions of chemotherapeutic agents can be given. Table 9 summarizes the long-term results from some of the recent studies performed with intra-arterial infusions. Historical comparison shows that patients with advanced head and neck cancer have poor long-term survival, ranging from 15 to 40% (50) . Unfortunately, large-scale randomized controlled studies are lacking. The largest, a series of 385 patients, looked at complications associated with intra-arterial chemotherapy infusions and found 10.6% of patients had chemotoxic events, with the majority involving the mucosa, 5.7% groin hematomas, and 1.5% neurological events (22) . The chemotoxic events reported were lower then those noted with intravenous administration of cisplatin (8) .
Intra-arterial infusions of chemotherapy seem to be safe and effective relative to historical controls. Results of these studies may help guide future study of intra-arterial therapy for intracranial tumors. Future randomized control studies will hopefully help to clarify the indications and dosages for this therapy.
CAROTID BLOWOUT SYNDROME
Carotid blowouts typically occur in the extracranial segment of the carotid artery as a result of invasion of malignant head and neck carcinomas into the carotid artery. The mortality rate for blowouts is 40% because of extravasation (10) . The typical presentation is copious, pulsating bleeding from the oropharynx.
This condition can be managed through endovascular methods. In patients with an intact circle of Willis who are able to tolerate a balloon test occlusion of the ipsilateral artery, complete sacrifice of the carotid artery is an option. This can be performed with detachable coils or detachable balloons with low morbidity (11) . Patients deemed to be at a high risk of stroke based on a failed balloon test occlusion can potentially be treated with stents covering the injured segment of artery (Fig. 4) . The placement of such stents is feasible and can stop extravasation (44) , but this is not a long-term solution. In the longer term, the artery continues to deteriorate, and the stents can extrude or become occluded over time, thus causing neurological morbidity (76, 82) . Additionally, patients are placed on antiplatelet therapy to maintain the patency of the stent, which may not be optimal in this group of patients.
CNS LYMPHOMA/GLIOMAS
Current therapies for malignant gliomas and lymphomas involve combination therapy using radiation, chemotherapy, and palliative surgery. Survival rates have been dismal despite such aggressive therapies, and newer therapeutic interventions have been studied using BBB disruption in combination with intra-arterial chemotherapy infusions.
This technique involves placing patients under general anesthesia. Selective catheterization of the target vessel ipsilateral to the tumor (i.e., ICA or vertebral artery) is performed. After injections of contrast material are performed, a determination is made as to the rate of infusion of mannitol based on the lowest infusion rate to achieve slight retrograde arterial filling from the catheter. At this point, 25% mannitol is infused for 30 seconds into the catheter at the rate determined necessary to disrupt the BBB. After 15 to 20 minutes, infusion of the chemotherapeutic agent is initiated (57) . Methotrexate is used for lymphomas, and carboplatin regimens are used for gliomas. Such protocols have been shown to be safe in Phase II studies enrolling more than 6000 patients and can be replicated across specialized centers (16) .
A Phase III randomized trial comparing the infusion of intra-arterial carmustine versus intravenous delivery postresection of malignant gliomas showed no difference between the two groups. Moreover, the intra-arterial group had significant side effects including white matter changes and encephalopathy (75) . Currently, a Phase III study is underway to determine the effectiveness of combing BBB disruption to intra-arterial delivery of chemotherapeutic agents in the hopes of extending life expectancies for these malignant tumors (19) .
CONCLUSION
We have summarized some of the therapies used by neurointerventionalists in the treatment of intracranial and head and neck cancers. Small case series have shown that there may be a role for these therapies in the future. Large multicenter randomized clinical trials are required to answer vital questions as to the risks and benefits of these therapeutic interventions.
